Author： Marschutz M.K. Veronese F.M. Bernkop-Schnurch A.
Publisher： Elsevier
ISSN： 0939-6411
Source： European Journal of Pharmaceutics and Biopharmaceutics, Vol.52, Iss.2, 2001-09, pp. : 137-144
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
By Freeman R.B. Yano K. Kimura S. Imanishi Y.
European Journal of Pharmaceutical Sciences, Vol. 7, Iss. 1, 1998-12 ,pp. :
Access to resources
Recommend
Current Pharmaceutical Design, Vol. 18, Iss. 20, 2012-07 ,pp. :
Pharmacokinetic Enhancement of Protease Inhibitor Therapy
By King J.R.
Clinical Pharmacokinetics, Vol. 43, Iss. 5, 2004-01 ,pp. :
Management of Protease Inhibitor-Associated Hyperlipidemia
By Penzak S.R.
American Journal of Cardiovascular Drugs, Vol. 2, Iss. 2, 2002-02 ,pp. :